HopeStage
Back to all studies
CompletedNCT00044187

Sibutramine for weight gain linked to olanzapine

About this title

The Assessment of a Weight-Gain Agent for the Treatment of Olanzapine-Associated Anti-Obesity Agent in Patients With Schizophrenia, Schizophreniform Disorder, Schizoaffective Disorder, and Bipolar I Disorder

Read the official source — NCT00044187
Medication studyAges 18–65United StatesBipolarity
The study in practice

Understand this study

Who was this study for?

Listed age limits: 18 years to 65 years.

Listed locations
El Centro and 15 more locationsSee all locations and recruitment
Study phase
Phase 4Usually happens after approval, to monitor real-world use, safety, and longer-term outcomes.

Get this study by email

HopeStage may email me about this study.
Loading the security check...
Study clarity

Study information

Study start dateApril 2001
Recruitment status
Completed
Enrollment listed in the registry
130
Sponsor
Eli Lilly and Company
Sponsor type
Other organization
Study type
Drug
Intervention type
Drug
Study phase
Phase 4Usually happens after approval, to monitor real-world use, safety, and longer-term outcomes.
Locations
United States
Age range
From 18 Years to 65 Years
Official registry ID
NCT00044187
Official title
Show the full official title

The Assessment of a Anti-Obesity Agent for the Treatment of Olanzapine-Associated Weight Gain in Patients With Schizophrenia, Schizophreniform Disorder, Schizoaffective Disorder and Bipolar I Disorder

Looking for a study you can join?

Explore recruiting studies

Recruitment & locations

Completed

El Centro · Jacksonville · Miami

13 more locations
  • Boise
  • Chicago
  • Indianapolis
  • Lafayette
  • Prairie Village
  • Milford
  • Clementon
  • Beachwood
  • Johnson City
  • Memphis
  • Houston
  • Richmond
  • Bellevue

Interested in joining this study?

HopeStage may email me about this study.
Loading the security check...
FAQ

Questions about this study

Who is behind this study?

The study sponsor is Eli Lilly and Company.

Did this study involve medication?

Yes. The study involved medication, including Sibutramine.

Who was this study for?

Listed age limits: 18 years to 65 years.

Want to explore more studies?

Explore studies